R01 CA105500/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2005	5
2006	3
2007	1
2008	6
2009	6
2010	3
2011	1
2012	2
2015	1
2016	1
2018	1
2025	0

1

Immunotherapy of cancer in 2012.

Kirkwood JM, Butterfield LH, Tarhini AA, Zarour H, Kalinski P, Ferrone S. Kirkwood JM, et al. CA Cancer J Clin. 2012 Sep-Oct;62(5):309-35. doi: 10.3322/caac.20132. Epub 2012 May 10. CA Cancer J Clin. 2012. PMID: 22576456 Free PMC article. Review.

2

Functional idiotopes: tumor antigen-directed expression of CD8+ T-cell epitopes nested in unique NH2-terminal VH sequence of antiidiotypic antibodies?

Kawano K, Ferrone S, Ioannides CG. Kawano K, et al. Cancer Res. 2005 Jul 15;65(14):6001-4. doi: 10.1158/0008-5472.CAN-04-3400. Cancer Res. 2005. PMID: 16024597 Review.

3

Immunotherapy of malignant disease with tumor antigen-specific monoclonal antibodies.

Campoli M, Ferris R, Ferrone S, Wang X. Campoli M, et al. Clin Cancer Res. 2010 Jan 1;16(1):11-20. doi: 10.1158/1078-0432.CCR-09-2345. Epub 2009 Dec 22. Clin Cancer Res. 2010. PMID: 20028761 Free PMC article. Review.

4

Functional and clinical relevance of chondroitin sulfate proteoglycan 4.

Campoli M, Ferrone S, Wang X. Campoli M, et al. Adv Cancer Res. 2010;109:73-121. doi: 10.1016/B978-0-12-380890-5.00003-X. Adv Cancer Res. 2010. PMID: 21070915 Review.

5

CSPG4 as a prognostic biomarker in chordoma.

Schoenfeld AJ, Wang X, Wang Y, Hornicek FJ, Nielsen GP, Duan Z, Ferrone S, Schwab JH. Schoenfeld AJ, et al. Spine J. 2016 Jun;16(6):722-7. doi: 10.1016/j.spinee.2015.11.059. Epub 2015 Dec 9. Spine J. 2016. PMID: 26689475 Free PMC article.

6

CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma.

Rivera Z, Ferrone S, Wang X, Jube S, Yang H, Pass HI, Kanodia S, Gaudino G, Carbone M. Rivera Z, et al. Clin Cancer Res. 2012 Oct 1;18(19):5352-63. doi: 10.1158/1078-0432.CCR-12-0628. Epub 2012 Aug 14. Clin Cancer Res. 2012. PMID: 22893632 Free PMC article.

7

Monoclonal antibodies for cancer immunotherapy.

Weiner LM, Dhodapkar MV, Ferrone S. Weiner LM, et al. Lancet. 2009 Mar 21;373(9668):1033-40. doi: 10.1016/S0140-6736(09)60251-8. Lancet. 2009. PMID: 19304016 Free PMC article. Review.

8

Presence and prognostic significance of melanoma-associated antigens CYT-MAA and HMW-MAA in serum of patients with melanoma.

Vergilis IJ, Szarek M, Ferrone S, Reynolds SR. Vergilis IJ, et al. J Invest Dermatol. 2005 Sep;125(3):526-31. doi: 10.1111/j.0022-202X.2005.23798.x. J Invest Dermatol. 2005. PMID: 16117794 Free article.

9

Mouse dendritic-endothelial cell hybrids and 4-1BB costimulation elicit antitumor effects mediated by broad antiangiogenic immunity.

Ko E, Luo W, Peng L, Wang X, Ferrone S. Ko E, et al. Cancer Res. 2007 Aug 15;67(16):7875-84. doi: 10.1158/0008-5472.CAN-06-1744. Cancer Res. 2007. PMID: 17699794

10

Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4.

Wang X, Katayama A, Wang Y, Yu L, Favoino E, Sakakura K, Favole A, Tsuchikawa T, Silver S, Watkins SC, Kageshita T, Ferrone S. Wang X, et al. Cancer Res. 2011 Dec 15;71(24):7410-22. doi: 10.1158/0008-5472.CAN-10-1134. Epub 2011 Oct 21. Cancer Res. 2011. PMID: 22021902 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year